Has the Bridge Between Regulatory and HTA Agencies Collapsed? Adapting to the Avalanche Unvalidated Surrogate Outcomes in Early Stage Cancer Trials
Author(s)
Robert Bick, PhD, CanCertainty, Markham, ON, Canada
This Discussion Group will focus on and feature speakers from the session Has the Bridge Between Regulatory and HTA Agencies Collapsed? Adapting to the Avalanche Unvalidated Surrogate Outcomes in Early Stage Cancer Trials (Monday, May 8, 10:15am – 11:15am)
Seating is limited.
Conference/Value in Health Info
2023-05, ISPOR 2023, Boston, MA, USA
Code
118
Topic
Clinical Outcomes